INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE
|
|
|
- Sharlene Edwards
- 5 years ago
- Views:
Transcription
1 INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE Combating Bacterial Resistance: many sizes to fit all Santiago de Cali, March 7TH, 8TH, 9TH 2018 Intercontinental Hotel Academic Program "Gato de Tejada" Tejada s Cat Emblematic Monument Santiago de Cali
2 WEDNESDAY 7MARCH Advances in Diagnosis: Transforming Infectious Diseases and The Study of Resistance Satellite Symposia Moderators: Germán Esparza and Lorena Díaz 2:00 2:30 Assessment of new rapid diagnostic platforms for the diagnosis of antimicrobial resistance. Robin Patel, Mayo Clinic. 2:30 3:00 Diagnosis of resistance using whole genome sequencing: How far we can get? Derrick Crook, Oxford University. 3:00-3:30 When the MIC is not helpful, Can genotype predict therapeutic success? Cesar A. Arias, University of Texas. 3:30 4:00 Coffee break 4:00 4:30 Implementation of whole genome sequencing in the clinical laboratory Derrick Crook, Oxford University. 4:30-5:00 Round table 5:00 5:30 Inauguration of the X International Symposium on Antimicrobial Resistance Moderator: Cesar Arias 5:30 6:15 John P. Quinn Lecture: Identifying mechanisms of resistance: from the lab to the clinician David Livermore, University of East Anglia
3 THURSDAY 8MARCH 7:00 8:30 Meet the Expert Moderators: José Oñate and María Virginia Villegas 9:00 9:30 The role of the microbiology laboratory in the 21st century Robin Patel, Mayo Clinic. 9:30 10:00 What's hot in the treatment of bacterial MDR organisms?: A clinician perspective David Van Duin, University of North Carolina. 10:00 10:30 Metallo-enzymes of Stenotrophomonas maltophilia and Burkholderia cepacia complex: A therapeutic challenge Maria Fernanda Mojica, Universidad El Bosque. 10:30 11:00 Coffee break 11:00 11:30 Mechanisms of resistance to new B-lactam/B-lactamase combinations: Clinical impact David Van Duin, University of North Carolina. 11:30 12:00 PK/PD considerations for optimizing beta-lactam/beta-lactam inhibitor conbinations. Vincent Tam, University of Houston. 12:00 12:30 Round table LUNCH and Satellite Symposia
4 Moderators: Carlos Cataño and Cesar Arias 2:00 2:30 New strategies for vancomycin dosage Michael Rybak, Wayne State University. 2:30 3:00 Emerging mechanisms of antibiotic resistance in Gram-positive bacteria: What have we learned Jinnethe Reyes, Universidad El Bosque. 3:00 3:30 Combination therapies for Gram-positive bacteria Michael Rybak. Wayne State University. 3:30 4:00 Coffee break 4:00 4:30 The pharmacology of the polymyxins: How to dose them Vincent Tam, University of Houston. 4:30 5:00 Tracking plasmid-mediated carbapenem resistance in Colombia: A challenge for infection control Laura Rojas, Case Western Reserve University. 5:00 5:30 AMS for surgical infections : what do we need to consider Christian Eckmann MD, PhD. 5:30 6:00 Carbapenemases: State of the art David Livermore, University of East Anglia. 6:00 6:30 Round table
5 FRIDAY 9MARCH 7:00 8:30 Meet the Expert Moderators: José Fernando García and Ernesto Martínez 9:00 9:30 Cleaning and Antiseptic Stewardship (CAS): a new paradigm Christian Pallares, Universidad El Bosque. 9:30 10:00 Antibiotic Stewardship in the era of rapid diagnostics Trish Perl, UT Southwestern, Dallas. 10:00 10:30 Coffee break 10:30 11:00 Effect of chlorhexidine bathing in preventing infections and reducing skin burden and environmental contamination: A review of the literature Trish Perl, UT Southwestern, Dallas. 11:00 11:30 Setting up an Antimicrobial Stewardship Program: from the theory to the implementation María Virginia Villegas, Universidad El Bosque. 11:30 12:00 Easy AMS outcomes: we can do it Cristhian Hernández, Universidad El Bosque. 12:00 12:30 Round table Satellite Simposia 2:00 Closure
6 SANTIAGO DE CALI TOURIST SITES Iglesia La Ermita RIO CALI Museo Arqueológico la Merced Cerro de las Tres Cruces Gato de Tejada Zoológico Parque del Avión Orquideorama Museo La Tertulia Jardín Botánico Cristo Rey Iglesia de San Antonio Hotel Intercontinental Simposium Hotel Sebastían de Belalcazar Biblioteca y Museo Departamental Estadio Pascual Guerrero Unidad Deportiva Plaza de Toros Zona Nor-Occidente Zona Nor-Oriente Distrito Agua Blanca Zona Oriente Zona Sur
7 INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE Combating Bacterial Resistance: many sizes to fit all Santiago de Cali, March 7TH, 8TH, 9TH 2018 Intercontinental Hotel Academic Program "Gato de Tejada" Tejada s Cat Emblematic Monument Santiago de Cali
Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"
Preserving the Power of Antibiotics Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli" Held on Thursday, September 30, 2004 in Boston, MA Preceding
GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
Best Practices for Antimicrobial Stewardship Programs. October 25, :00 AM 5:00 PM New Orleans, LA Room:
Best Practices for Antimicrobial Stewardship Programs October 25, 2016 8:00 AM 5:00 PM New Orleans, LA Room: 288-290 Co-organized by The Society for Healthcare Epidemiology of America (SHEA) and Pediatric
VIII V INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE INTERNATIONAL SYMPOSIUM ON HEALTHCARE ASSOCIATED INFECTIONS
VIII V INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE INTERNATIONAL SYMPOSIUM ON HEALTHCARE ASSOCIATED INFECTIONS March 5-7, 2014 Cartagena, Colombia Hotel Las Américas, Convention Center Symposium
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
Mechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
CONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
Mestre-Venice, October 25 th -26 th NH Laguna Palace Hotel Mestre, Venice
3 rd edition Mestre-Venice, October 25 th -26 th 2018 NH Laguna Palace Hotel Mestre, Venice Chairman Matteo Bassetti (Italy) Co-Chairman David P. Nicolau (USA) International Scientific committee A. Brink
What s next in the antibiotic pipeline?
What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics
MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta
MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
Antimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
Antimicrobial Resistance Initiative
Antimicrobial Resistance Initiative Antimicrobial Resistance Initiative Resistance to antimicrobial agents has become a threat to public health all over the world. Microorganisms become resistant to antimicrobial
Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
CONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
Why we perform susceptibility testing
22 nd June 2015 Why we perform susceptibility testing Robin A Howe Antimicrobial use in Primary Care Why do we perform AST? Clinical Clinical Prediction Prediction of of Efficacy Efficacy Why do we perform
Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities
REVIEW Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities Fiona Walsh Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland
ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections
ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections Robin Isaacs Chief Medical Officer, Entasis Therapeutics Dr. Isaacs is a full-time employee of Entasis Therapeutics.
Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results
White Paper: Templated Report Comments Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results Background The availability of rapid, multiplexed technologies for the comprehensive
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
WORKSHOP AGENDA. Coordinated Research Initiative for the Implementation of Antimicrobial Resistance Control Strategies (CTI A (SCSC))
Coordinated Research Initiative for the Implementation of Antimicrobial Resistance Control Strategies (CTI 25 2014A (SCSC)) Day 1 Awareness Objective: Enhance awareness, skills and knowledge in the field
CITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP PROGRAMME
CITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP commissioned by the All Wales Medicines Strategy Group Tuesday 5 th Friday 8 th July 2016 Cardiff City Hall Cathays Park, Cardiff CF10 3ND PROGRAMME THE QUESTION
Surveillance of AMR in PHE: a multidisciplinary,
Surveillance of AMR in PHE: a multidisciplinary, integrated approach Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright International
ESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL
Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL David P. Nicolau, PharmD, FCCP, FIDSA Director, Center for Anti-Infective Research and Development Hartford Hospital
Amoxicillin clavulanic acid spectrum
Cari untuk: Cari Cari Amoxicillin clavulanic acid spectrum 14-8-2017 Amoxicillin and clavulanate potassium (AMC), also known as augmentin, is an antibiotic used to treat bacterial infections. AMC is available
Fighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
Implementation and Optimization of Antibiotic Stewardship in Acute Care Hospitals: A Clinical Microbiology Laboratory Perspective
Implementation and Optimization of Antibiotic Stewardship in Acute Care Hospitals: A Clinical Microbiology Laboratory Perspective James E. Kirby, MD D(ABMM) Medical Director, Clinical Microbiology Beth
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
ANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
Antimicrobial stewardship
Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the
Resistant Gram-negative Bacteria
Introduction Antibiotic-resistant bacteria aren t new. But gram-negative bacteria, like Enterobacteriaceae, are becoming more resistant to our last-line antibiotics. Some people are calling these bacteria
Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials
Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site
Antibiotic Discovery and Development
Thomas J. Dougherty Michael J. Pucci Editors Antibiotic Discovery and Development ringer VOLUME I Part I Introductory History of Antimicrobial Drugs 1 The Early History of Antibiotic Discovery: Empiricism
Antimicrobial Stewardship: The South African Perspective
Antimicrobial Stewardship: The South African Perspective Precious Matsoso Director General; National Department of Health; South Africa 13 th November 2015 Why do we need an AMR strategy and implementation
Pierre-Louis Toutain, Ecole Nationale Vétérinaire National veterinary School of Toulouse, France Wuhan 12/10/2015
Antimicrobial susceptibility testing for amoxicillin in pigs: the setting of the PK/PD cutoff value using population kinetic and Monte Carlo Simulation Pierre-Louis Toutain, Ecole Nationale Vétérinaire
Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark
Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Programme anaerobic bacteria Carbapenem and metronidazole resistance New
Rise of Resistance: From MRSA to CRE
Rise of Resistance: From MRSA to CRE Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine SUPERBUGS (AKA MDROs) MRSA Methicillin-resistant S. aureus Evolution of Drug Resistance
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
Antimicrobial susceptibility testing challenges. Linda Joyce St Vincent s Hospital Melbourne
Antimicrobial susceptibility testing challenges Linda Joyce St Vincent s Hospital Melbourne Bacteria/antimicrobials without breakpoints (B.A.W.B.S.) Enterobacteriacae Pseudomonas aeruginosa, Acinetobacter
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
Jump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS
HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA
Overview of antibiotic combination issues.
Overview of antibiotic combination issues. Professor Anthony Coates St George s, University of London Founder, CSO, Helperby Therapeutics Ltd The most serious problem is Carbapenem resistant Gram-negatives
Hosted by Dr. Benedetta Allegranzi, WHO Patient Safety Agency A Webber Training Teleclass
The History of Medicine Antimicrobial Resistance Issues Worldwide and the WHO Approach to Combat It Carmem Lúcia Pessoa-Silva, MD, PhD Health Security and Environment Cluster, WHO HQ, Geneva Hosted by
Summary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
Antimicrobial stewardship as a tool to fight resistance
Havana, septiembre 2018 Antimicrobial stewardship as a tool to fight resistance José Miguel Cisneros Herreros Infectious Diseases Department University Hospital Virgen del Rocío, Sevilla, SPAIN Competing
Multi-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
RxPress. May/Jun Vol 16 No 3. The White House Releases Plan to Combat Antibiotic-Resistant Bacteria
May/Jun 2015 Vol 16 No 3 RxPress TABLE OF CONTENTS The White House Releases Plan to Combat Antibiotic-Resistant Bacteria 1-2 FDA Requests New Data on Health Care Antiseptics 2-4 Penicillin Allergies and
Other Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
Appropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science
SZENT ISTVÁN UNIVERSITY Doctoral School of Veterinary Science Comparative pharmacokinetics of the amoxicillinclavulanic acid combination in broiler chickens and turkeys, susceptibility and stability tests
11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
CONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
Rational use of antibiotics
Rational use of antibiotics Uga Dumpis MD, PhD,, DTM Stradins University Hospital Riga, Latvia ugadumpis@stradini.lv BALTICCARE CONFERENCE, PSKOV, 16-18.03, 18.03, 2006 Why to use antibiotics? Prophylaxis
Antimicrobial stewardship in companion animals: Welcome to a whole new era
Antimicrobial stewardship in companion animals: Welcome to a whole new era John F. Prescott, University Professor Emeritus, Department of Pathobiology, University of Guelph, Guelph, Ontario NG 2W1 prescott@uoguelph.ca
TREAT Steward. Antimicrobial Stewardship software with personalized decision support
TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
Antimicrobial Stewardship
Antimicrobial Stewardship Preventing the Spread of Antibiotic Resistance and Improving Patient Care (Adapted from the Centers for Disease Control and Prevention) What is Stewardship? Antimicrobial stewardship
Sepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts
Objectives Understand the application of Antibiotic Stewardship regulations in LTC Understand past barriers to antibiotic management concepts Understand benefits of adoption of antibiotic stewardship regulations
Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
Enhancing practitioner knowledge and adoption of infection prevention and control measures for both food and companion animal veterinarians
Enhancing practitioner knowledge and adoption of infection prevention and control measures for both food and companion animal veterinarians NAS Workshop Session 2 Part B June 20, 2017 H. Morgan Scott DVM,
C&W Three-Year Cumulative Antibiogram January 2013 December 2015
C&W Three-Year Cumulative Antibiogram January 213 December 215 Division of Microbiology, Virology & Infection Control Department of Pathology & Laboratory Medicine Contents Comments and Limitations...
Antimicrobial Stewardship: efective implementation for improved clinical outcomes
The Challenge of MDR and XDR infections; Barcelona September 2018 Antimicrobial Stewardship: efective implementation for improved clinical outcomes José Miguel Cisneros Herreros Infectious Diseases Department
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
Antimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014
DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION Cara Wilder Ph.D. Technical Writer March 13 th 2014 ATCC Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas,
Burkholderia cepacia. Clinica Veterinaria Vezzoni - Cremona, Italy
Burkholderia cepacia Clinica Veterinaria Vezzoni - Cremona, Italy Clinical experience of epidemic outbreak Positive culture for Burkholderia cepacea in the surgical site end of surgery Repeatedly positive
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
LEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES INFECTIOUS DISEASE SCARES
LEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES Goodbye to the Antibiotic Era? Glenn D. Bedsole, MD, FACP Infectious Disease Consultant 1. Be able to list 6 examples of resistant bacteria that present
UDC: : :579.22/ :615.28
www.imiamn.org.ua /journal.htm 8 UDC: 6.33:61.017.1:579./.841.9:6.8 SUBSTANTIATION OF OVERCOMING OF ANTIBIOTIC RESISTANCE IN ACINETOBACTER BAUMANNII CLINICAL STRAINS BY USAGE OF DECAMETHOXINUM Nazarchuk
Antibiotic Stewardship in Human Health- Progress and Opportunities
National Center for Emerging and Zoonotic Infectious Diseases Antibiotic Stewardship in Human Health- Progress and Opportunities CAPT Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship Division
Curricular Components for Infectious Diseases EPA
Curricular Components for Infectious Diseases EPA 1. EPA Title Promoting antimicrobial stewardship based on microbiological principles 2. Description of the A key role for subspecialists is to utilize
A snapshot of polymyxin use around the world South America
A snapshot of polymyxin use around the world South America Alexandre P. Zavascki Infectious Diseases Service, Hospital de Clínicas de Porto Alegre Medical School, Federal University of Rio Grande do Sul
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;
Sequential Application of Hand Antiseptic for Use in No-Water Situations (dubbed SaniTwice) A New Hand Hygiene Option Robert R. McCormack BioScience Laboratories, Inc. March 25, 2009 BioScience Laboratories,
Infectious Disease: Drug Resistance Pattern in New Mexico
Infectious Disease: Drug Resistance Pattern in New Mexico Are these the world's sexiest accents? Obi C. Okoli, MD.,MPH. Clinic for Infectious Diseases Las Cruces, NM. Are these the world's sexiest accents?
Intrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
DR. BASHIRU BOI KIKIMOTO
OVERVIEW OF ANTIMICROBIAL RESISTANCE AND ANTIMICROBIAL USE IN GHANA PRESENTED BY : DR. BASHIRU BOI KIKIMOTO DVM. PhD VETERINARY PUBLIC HEALTH HEAD - PUBLIC HEALTH UNIT & FOOD SAFETY UNIT VENUE: SWATZILAND
BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity
BIOLACTAM www.biolactam.eu An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity 1.5-3h 20 Copyright 2014 VL-Diagnostics GmbH. All rights reserved. Product
The Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
The European road map against antimicrobial resistance
The European road map against antimicrobial resistance (a changing paradigm for drug discovery and development?) Paul M. Tulkens*, MD, PhD Cellular and Molecular Pharmacology Louvain Drug Research Institute
4/17/2013. Antimicrobial Stewardship: pengalaman di Belanda. Henri A. Verbrugh MD PhD. number of emerging infectious diseases events per decade
Antimicrobial Stewardship: pengalaman di Belanda Henri A. Verbrugh MD PhD KE Jones et al., Nature 2008 EID is disease caused by a pathogen that has recently evolved or entered the human population for
Perspective on AnA Global timicrobial Resistance
National Center for Emerging and Zoonotic Infectious Diseases Perspective on AnA Global timicrobial Resistance Dawn M. Sievert, PhD, MS Associate Director for Antimicrobial Resistance Division of Foodborne,
Advancing Antimicrobial Stewardship in Community and Rural Hospitals
Advancing Antimicrobial Stewardship in Community and Rural Hospitals Whitney Buckel, PharmD, BCPS Infectious Diseases Clinical Pharmacist Intermountain Medical Center Disclosures The SCORE study was supported
Antimicrobial Selection to Combat Resistance
Antimicrobial Selection to Combat Resistance (Dead Bugs Don t Mutate!) Shelley C Rankin PhD Associate Professor CE Microbiology Head of Diagnostic Services & Chief of Clinical Microbiology Ryan Veterinary
2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania
2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania Day 1: Saturday 30 th September 2017 09:00 09:20 Registration
Hospital ID: 831. Bourguiba Hospital. Tertiary hospital
Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017
Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance
Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance Christiane Santiago Maia ANVISA - Brazilian Health Regulatory Agency s Context The burden of deaths from
Physician Rating: ( 23 Votes ) Rate This Article:
From Medscape Infectious Diseases Conquering Antibiotic Overuse An Expert Interview With the CDC Laura A. Stokowski, RN, MS Authors and Disclosures Posted: 11/30/2010 Physician Rating: ( 23 Votes ) Rate
Monthly Webinar. Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm. Event number: Audio dial-in (phone):
Monthly Webinar Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm Event number: 849 291 546 Audio dial-in (phone): 01 526 0058 AMS InSight Monthly Webinar: Tuesday 12th December MicroB: Brewing
Antimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger